Trial intelligence / Profile preview

ATLANTIC: Pre-hospital vs In-hospital Ticagrelor in STEMI

NCT01347580Phase 4Completed

Sponsor
AstraZeneca
Start
Sep 2011
Primary completion
Nov 2013
Modality
Small Molecules
Countries
13
01

Overview

A Phase 4 trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by AstraZeneca. Started Sep 2011; status: completed.

02

Drugs

ticagrelor
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT01347580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01347580.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call